• MD Stem Cells studies treatment for NAION

    2 days ago - By Healio

    Steven Levy, MD, and his MD Stem Cells team have seen statistically significant results using stem cells to fight degenerative eye diseases such as retinitis pigmentosa and non-arteritic ischemic optic neuropathy.
    In the NAION study, 10 patients with bilateral visual loss due to sequential non-arteritic ischemic optic neuropathy underwent autologous bone marrow-derived stem cell therapy in the Stem Cell Ophthalmology Treatment Study .
    Average patient age was 69.8 years, with an average duration of 9.8 years of visual loss.
    Affected eyes were treated with either ocular injections of
    Read more ...